Skip to main content

Hepion in the News

 About Hepion
Recent News
 Contact Us
Hepion
In Media Placements

Hepion Pharmaceuticals’ CEO Robert Foster discusses CRV431’s potential in NASH [BioTuesdays]

https://www.biotuesdays.com/features/2019/7/30/hepion-pharmaceuticals-ceo-robert-foster-discusses-crv431s-potential-in-nash
Hepion
In Media Placements

Robert Foster swinging for the fence again with Hepion Pharma [BioTuesdays]

http://www.biotuesdays.com/features/2018/11/7/robert-foster-swinging-for-the-fence-again-with-contravir-pharma
Hepion
In Media Placements

An Update on Hepatitis B Therapies [Drug Discovery World]

http://www.ddw-online.com/fall-2016/p315872-an-update-on-hepatitis-b-therapies.html
Hepion
In Media Placements

Dr. Robert Foster, Chief Scientific Officer of Hepion, invited to join the Faculty of Pharmacy & Pharmaceutical Sciences at the University of Alberta as an Honorary Professor

https://hepionpharma.com/wp-content/uploads/2016/07/RTF-Professorship.pdf
Hepion
In Media Placements

The Rise of the CFO Strategist: Balancing Numbers and Know-how [Via PharmaExec]

http://www.pharmexec.com/rise-cfo-strategist-balancing-numbers-and-know-how
Hepion
In Media Placements

Hepion Hopes To Establish Backbone For Hepatitis B Combo Therapy [via Scrip]

https://scrip.pharmamedtechbi.com/SC096933/Hepion-Hopes-To-Establish-Backbone-For-Hepatitis-B-Combo-Therapy
Hepion
In Media Placements

Should Gilead Sciences Feel Threatened By Hepion’s Hepatitis B Drug? [via Bidness Etc]

http://www.bidnessetc.com/66362-gilead-sciences-feel-threatened-contravirs-hepatitis-b-drug/

Media Contact